Neurons expressing somatostatin receptor 4 (SSTR4) represent an important subset of somatostatin receptor-expressing neurons in the central nervous system. SSTR4 is a G protein-coupled receptor (GPCR) that mediates the inhibitory effects of somatostatin on neuronal activity. SSTR4 has distinct pharmacological properties and brain distribution compared to other SSTR subtypes.
SSTR4-expressing neurons are prominently found in:
- Cerebral cortex — highest density in layers 2-4, involved in cortical processing
- Hippocampus — particularly CA1 and CA3 regions
- Amygdala — concentrated in the basolateral amygdala
- Thalamus — in relay nuclei
- Spinal cord — in dorsal horn regions
SSTR4 plays a crucial role in cognitive function:
- Modulates synaptic plasticity in hippocampus
- Influences memory consolidation and retrieval
- Regulates fear conditioning and emotional memory
- SSTR4 in amygdala modulates anxiety-like behaviors
- Agonists produce anxiolytic effects
- Altered expression in anxiety disorders
- SSTR4 expressed in spinal cord dorsal horn
- Mediates analgesic effects of somatostatin
- Modulates nociceptive transmission
- Regulates cortical neuron excitability
- Influences sensory integration
- May play role in attention
- SSTR4 binding is reduced in AD hippocampus
- Loss of SSTR4 contributes to memory deficits
- Somatostatin/SSTR4 axis is a therapeutic target
- Agonists may improve cognitive function
- SSTR4 agonists being developed for chronic pain
- Potential for neuropathic pain treatment
- Modulates central sensitization
- Altered SSTR4 expression in depression
- Related to emotional processing deficits
- Novel antidepressant targets
SSTR4 couples to Gi/o proteins:
- Inhibits adenylyl cyclase → reduces cAMP
- Activates potassium channels → hyperpolarization
- Modulates MAP kinase pathways
- Regulates calcium signaling
SSTR4 is a promising drug target for:
- Cognitive enhancement in neurodegeneration
- Chronic pain management
- Anxiety and depression treatment
- Neuroprotective strategies
- SSTR4 in cognition and pain (2019)
- Somatostatin receptors in Alzheimer's disease (2020)
- SSTR4 and anxiety: preclinical findings (2018)
- Somatostatin analgesia and SSTR4 (2021)
- SSTR4 in synaptic plasticity (2017)